---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-25-006266"
form_type: "8-K"
ticker: "XBIT"
cik: "0001626878"
company_name: "XBiotech Inc."
filed_at: "2025-10-03T23:59:59+00:00"
generated_at: "2026-05-17T04:45:19.313874+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# XBiotech enters new employment agreement with CEO John Simard; $1.25M salary, $4.53M bonus baseline

## Summary
- Base salary unchanged at $1.25M; annual bonus baseline set at $4.53M for 2025, both inflation-adjusted annually.
- Severance: 3 years base salary + 3 years base bonus if terminated without cause, disability, or retirement; 80% if for cause.
- Upon retirement, CEO to consult for 18 months receiving additional base salary payments plus severance.
- Agreement formalizes compensation trends over past 5 years; approved by Compensation Committee of independent directors.
- Executive remains CEO and President; no change in leadership roles.

## SEC filing metadata
- accession: 0001171843-25-006266
- form_type: 8-K
- ticker: XBIT
- cik: 0001626878
- company_name: XBiotech Inc.
- filed_at: 2025-10-03T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1626878/000117184325006266/0001171843-25-006266-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1626878/000117184325006266/f8k_100325.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-25-006266
- JSON: https://secwatch.observer/filing/0001171843-25-006266.json
- Plain text: https://secwatch.observer/filing/0001171843-25-006266.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.